Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA-Approved Nasal Spray For Depression Is 1st Of Its Kind
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD, and similar psychiatric conditions.
FDA OKs Esketamine Nasal Spray Monotherapy for Resistant Depression
The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not responded to at least two oral antidepressants.
Healthline
5d
Migraine Nasal Sprays Explained
Nasal
sprays
can be an effective medication option to manage migraine symptoms. Often,
nasal
sprays
can provide faster relief than oral medication. You may have heard of
nasal
sprays
as a ...
1d
on MSN
Can a nasal spray cure loneliness? Effects of hormone spritz lasted for months in study
Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
Hamas releases 4 hostages
Confirmed to lead Pentagon
DOJ drops charges
Escaped monkeys captured
Consumer sentiment falls
‘Walk It Out’ rapper dies
PETA activists arrested
Woman arrested in shooting
Proposed ban withdrawn
Target ending its DEI goals
Jabrill Peppers testifies
Wins first Grand Slam title
Carroll to coach Raiders
Assault trial begins
Pandas make public debut
DOJ drops case
Wallen announces tour
US home sales fell
Debuts AI assistant
Suspends all trips to Yemen
Alleged assault cover-up suit
Barred from entering DC
Newark mayor criticizes raid
Ex-Nebraska RB Jones dies
Proposes ending FEMA
Crack down on fake reviews
Millions missed school
Manson won't face charges
Trump ends security detail
Related topics
depression
FDA
Food and Drug Administration
Johnson & Johnson
Feedback